de Ornelas Maia Ana Claudia C, Soares-Filho Gastão, Pereira Valeska, Nardi Antonio Egidio, Silva Adriana Cardoso
Laboratory of Panic and Respiration, Institute of Psychiatry (Drs Soares-Filho and Silva and Mss Ornelas Maia and Pereira) and National Institute for Science and Technology, Translational Medicine (Drs Nardi and Silva), Federal University of Rio de Janeiro; and National Institute for Science and Technology, Translational Medicine, Federal University Fluminense (Dr Silva), Rio de Janeiro, Brazil.
Prim Care Companion CNS Disord. 2013;15(2). doi: 10.4088/PCC.12r01456. Epub 2013 Apr 18.
To systematically review the literature with regard to psychiatric disorders and quality of life in patients with an implantable cardioverter defibrillator.
Research was conducted in 3 databases (ISI Web of Science, PubMed, and PsycINFO) using the terms implantable, cardioverter, defibrillator, quality of life, psych *, anxiety, and depression.
The search yielded 1,399 references. Non-English and repeated references were excluded. After abstract analysis, 42 references were recovered for full-text reading, and 25 articles were selected for this review.
Research took place in April 2012, and no time restriction was placed on any of the database searches. Review or theoretical articles were excluded, and only clinical trials and epidemiologic studies were selected for this review.
A systematic review of the literature revealed mostly observational prospective cohort studies followed by cross-sectional observational studies and randomized clinical trials. Few studies included in the review were observational retrospective cohort or case-control studies. There are prominent signs and symptoms of anxiety and depression in patients with an implantable cardioverter defibrillator. Disorders include phobic anxiety, posttraumatic stress disorder, panic disorder, somatoform disorder, agoraphobia, and depression. Quality of life in the physical, social, and psychological domains is affected and is related to the intensity and the frequency of the device's electrical discharge.
Work regarding psychiatric comorbidity in patients with an implantable cardioverter defibrillator has shown that anxiety and depression are common. The patients and their families should be informed by their doctors that the presence of the device minimizes risk of sudden death and allows them to have a normal life.
系统回顾有关植入式心脏复律除颤器患者的精神障碍与生活质量的文献。
在3个数据库（科学网、PubMed和PsycINFO）中进行检索，使用的检索词为植入式、心脏复律器、除颤器、生活质量、精神*、焦虑和抑郁。
检索得到1399篇参考文献。排除非英文文献和重复文献。经摘要分析后，回收42篇参考文献进行全文阅读，最终选取25篇文章纳入本综述。
研究于2012年4月进行，对任何数据库检索均无时间限制。排除综述或理论性文章，仅选择临床试验和流行病学研究纳入本综述。
对文献的系统回顾显示，大多为观察性前瞻性队列研究，其次是横断面观察性研究和随机临床试验。纳入综述的研究中很少有观察性回顾性队列或病例对照研究。植入式心脏复律除颤器患者存在焦虑和抑郁的显著体征和症状。相关障碍包括恐惧性焦虑、创伤后应激障碍、惊恐障碍、躯体形式障碍、广场恐惧症和抑郁症。身体、社会和心理领域的生活质量均受到影响，且与设备放电的强度和频率有关。
关于植入式心脏复律除颤器患者精神共病的研究表明，焦虑和抑郁很常见。医生应告知患者及其家属，该设备的存在可将猝死风险降至最低，并使他们能够正常生活。
